Topics

Collegium secures $339M through term loan agreement, public debt raise to finance Nucynta deal

19:40 EST 11 Feb 2020 | Elsevier Business Intelligence

Collegium Pharmaceutical Inc. received a total of $339.4M in committed debt financing to support in part its concurrent $375M...

Original Article: Collegium secures $339M through term loan agreement, public debt raise to finance Nucynta deal

NEXT ARTICLE

More From BioPortfolio on "Collegium secures $339M through term loan agreement, public debt raise to finance Nucynta deal"

Quick Search

Relevant Topics

Pain
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...